Why did CDC pause rabies testing?

CDC pauses rabies and other infectious disease testing

The CDC temporarily stopped testing for rabies and pox viruses for state and local public health labs. The immediate driver is staffing strain: federal support that normally helps labs run specialized tests has been reduced as staff departures and shortages leave fewer personnel available.

The change matters because rabies is a rare but nearly always fatal disease once symptoms begin. While the CDC did not describe the exact scope of how cases will be managed in the meantime, pausing testing shifts the burden onto local systems and may delay confirmation for suspected cases.

Health officials and experts expressed concern that the testing interruption could reduce the speed and capacity of the national public health response—especially in outbreaks or areas that detect increases in exposure risks. This is especially relevant given the broader context described with the pause: reports of rising rabies activity in multiple parts of the U.S., alongside concerns about how shrinking habitats and surveillance changes affect where and how the virus is found.

A separate related update also indicates the CDC temporarily halted testing for several infectious diseases due to similar staffing shortages, reinforcing that the issue is systemic rather than limited to one pathogen.

What to watch next

• Whether CDC expands testing back to prior levels as staffing improves
• How states route suspected cases for confirmation testing
• Whether turnaround times for results change in high-risk regions

For patients and clinicians, the key implication is operational: when public health labs face capacity limits, confirmation testing can be slower, and guidance on exposure management becomes even more important while the system adjusts.